1.Research on integrated application of tumor magnetic induction hyperthermia treatment planning system and modern medical information systems.
Zihan ZHUO ; Weiming ZHAI ; Dongyang CAI ; Jie WANG ; Xiaodong ZHANG ; Jintian TANG
Journal of Biomedical Engineering 2014;31(1):187-191
Magnetic induction hyperthermia becomes a very important tumor treatment method at present. In order to ensure a successful operation, doctors should make hyperthermia treatment planning before surgery. Based on Integration Healthcare Enterprise (IHE) framework and Digital Imaging and Communications in Medcine (DICOM) standard, we proposed and carried out a network workflow integrated with modern medical information systems for the dissemination of information in magnetic induction hyperthermia like accurate accessing patient information and radiology image data, storing processed images, sharing and verifying hyperthermia reports. The results proved that our system could not only improve the efficiency of magnetic induction hyperthermia treatment planning, but also save medical resources and reduce labor costs.
Humans
;
Hyperthermia, Induced
;
Image Processing, Computer-Assisted
;
Magnetic Phenomena
;
Neoplasms
;
therapy
;
Radiology Information Systems
;
Systems Integration
2.Recent advance in interaction between acute subdural hematoma and disorder of intracranial superficial venous circulation
Weiming XU ; Shuwen MU ; Wei WANG ; Hengheng ZHAI ; Shousen WANG
Chinese Journal of Neuromedicine 2020;19(1):98-101
Traumatic acute subdural hematoma (ASDH) is often severe,and bridging vein rupture is one of the case mechanisms of ASDH.After traumatic ASDH,venous reflux disorder,cerebral ischemia,delayed bleeding in other parts of the brain,and intraoperative encephalocele are prone to occur.This article reviews the occurrence and development of ASDH and its relation with intracranial venous circulation.
3.Analysis of the efficacy and prognostic factors of 1 637 esophageal cancer patients treated with intensity-modulated radiotherapy
Chen LI ; Lijun TAN ; Xiao LIU ; Weiming HAN ; Linrui GAO ; Shijia WANG ; Zongmei ZHOU ; Qinfu FENG ; Dongfu CHEN ; Jun LIANG ; Jima LYU ; Wenqing WANG ; Zhouguang HUI ; Lyuhua WANG ; Xin WANG ; Wenyang LIU ; Lei DENG ; Jianyang WANG ; Yirui ZHAI ; Tao ZHANG ; Nan BI ; Zefen XIAO
Chinese Journal of Oncology 2021;43(6):678-684
Objective:To summarize survival outcomes and prognostic factors in esophageal cancer (EC) patients treated with intensity-modulated radiotherapy (IMRT).Methods:A retrospective analysis was performed on the clinical and follow-up data of 1 637 patients with EC who were admitted to our hospital from January 2005 to December 2017 and met the inclusion criteria.The 5-year overall survival (OS), progression-free survival (PFS) and pattern of recurrence were analyzed. The Kaplan-Meier method was used to calculate survival rates, Log-rank test for univariate analysis and Cox method for multivariate analysis were used to detect survival difference.Results:1-year, 3-year and 5-year OS and PFS of the entire group were 65.9% and 45.8%, 34.2% and 25.0%, 27.0% and 18.5%, respectively. Median OS and PFS were 19.4 months (95% CI=18.0-20.7 months) and 10.4 months (95% CI=9.3-11.3 months), respectively. Univariate analysis showed that the sex, KPS, tumor location, T stage, N stage, M stage, TNM stage, radiation dose and treatment modality were prognostic factors for 5-year OS and PFS of EC patients ( P<0.05). Multivariate analysis indicated that the sex, KPS, TNM stage, radiation dose and treatment modality were independent prognostic factors for 5-year OS and PFS ( P<0.05). Conclusions:EC patients treated with IMRT can obtain a promising survival. The sex, KPS, TNM stage, radiation dose and treatment modality are independent prognostic factors for prognosis.
4.Analysis of the efficacy and prognostic factors of 1 637 esophageal cancer patients treated with intensity-modulated radiotherapy
Chen LI ; Lijun TAN ; Xiao LIU ; Weiming HAN ; Linrui GAO ; Shijia WANG ; Zongmei ZHOU ; Qinfu FENG ; Dongfu CHEN ; Jun LIANG ; Jima LYU ; Wenqing WANG ; Zhouguang HUI ; Lyuhua WANG ; Xin WANG ; Wenyang LIU ; Lei DENG ; Jianyang WANG ; Yirui ZHAI ; Tao ZHANG ; Nan BI ; Zefen XIAO
Chinese Journal of Oncology 2021;43(6):678-684
Objective:To summarize survival outcomes and prognostic factors in esophageal cancer (EC) patients treated with intensity-modulated radiotherapy (IMRT).Methods:A retrospective analysis was performed on the clinical and follow-up data of 1 637 patients with EC who were admitted to our hospital from January 2005 to December 2017 and met the inclusion criteria.The 5-year overall survival (OS), progression-free survival (PFS) and pattern of recurrence were analyzed. The Kaplan-Meier method was used to calculate survival rates, Log-rank test for univariate analysis and Cox method for multivariate analysis were used to detect survival difference.Results:1-year, 3-year and 5-year OS and PFS of the entire group were 65.9% and 45.8%, 34.2% and 25.0%, 27.0% and 18.5%, respectively. Median OS and PFS were 19.4 months (95% CI=18.0-20.7 months) and 10.4 months (95% CI=9.3-11.3 months), respectively. Univariate analysis showed that the sex, KPS, tumor location, T stage, N stage, M stage, TNM stage, radiation dose and treatment modality were prognostic factors for 5-year OS and PFS of EC patients ( P<0.05). Multivariate analysis indicated that the sex, KPS, TNM stage, radiation dose and treatment modality were independent prognostic factors for 5-year OS and PFS ( P<0.05). Conclusions:EC patients treated with IMRT can obtain a promising survival. The sex, KPS, TNM stage, radiation dose and treatment modality are independent prognostic factors for prognosis.